Lin Zhu

9PUBLICATIONS
11CO-AUTHORS
Pharmaceutical delivery technologiesRadiation therapyPredictive and prognostic markersCancer diagnosisAnimal production not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
Development and Advantages of O-(Carboxymethyl)-L-tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer.

|Apr 29, 2026
Development and Preclinical Evaluation of Dual-Target 68Ga/177Lu-Labeled FAP-Bisphosphonate Radioligands with Enhanced Osteoma Retention.

|Aug 19, 2025
PSMA PET/CT for Improved Staging Accuracy and Imaging of Neovascularization-associated Features in Primary Lung Cancer.

Ruiyue Zhao, Jinhui Liu, Wanmei Liang

|May 05, 2025
Bisphosphonate Bone Imaging Agent [68Ga]Ga-P15-041 for Evaluating Skeletal Metastases in Prostate Cancer: A Comparison With [68Ga]Ga-PSMA-11 PET/CT.

Jiarou Wang, Linlin Li, Tianrui Feng

|Nov 05, 2024
Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4.

Linlin Li, Guochang Wang, Jiarou Wang

|Jul 16, 2021
A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain.

Hao Xiao, Seok Rye Choi, Ruiyue Zhao

Pageof 2

Frequent Collaborators

6 joint publications

Hank F Kung

3 joint publications

Karl Ploessl

2 joint publications

Rongxi Wang

2 joint publications

Yaping Luo